Iberoamerican Journal of Medicine
Iberoamerican Journal of Medicine
Original article

Evaluation of Inflammatory Hematological Ratios (NLR, PLR, MLR and Monocyte/HDL-Cholesterol Ratio) in Obese Adolescents

Evaluación de las relaciones hematológicas inflamatorias (NLR, PLR, MLR y relación monocitos / colesterol HDL) en adolescentes obesos

Emine Türkkan, Nevin Çetin Dağ, Çiğdem Arabacı, Okan Dikker, Hüseyin Dağ

Downloads: 2
Views: 740


Introduction: Obesity is a gradually more important multifactorial disease in both children and adults. Obese children and adolescents are at higher risk of becoming obese in adulthood, which is associated with an increased risk of mortality and morbidity. There is subclinical systemic inflammation in obesity. The study aimed to evaluate the hematological parameters as an indicator of inflammation in obese adolescents and to show the relationship of monocyte/HDL-cholesterol ratio, having a lipid component, with other inflammatory hematological parameters.
Materials and methods: We retrospectively reviewed the medical files of 60 patients, 30 obese and 30 healthy controls, aged between 11 and 16 years, who applied to the pediatric outpatient clinic. Laboratory tests, hematological parameters, gender, age, and BMI were compared between the groups. Correlations between monocyte/HDL-cholesterol ratio and other laboratory parameters in the obese group were examined.
Results: BMI, Alanine aminotransferase (ALT), C-reactive protein (CRP), triglyceride, insulin, and HOMA-IR levels of the obese adolescent group were statistically significantly higher than the control group (p<0.05). There was no statistically significant difference between the obese and control groups in terms of inflammatory hematological ratios (NLR, PLR, MLR, and monocyte/HDL-cholesterol ratio) (p>0.05). There was no statistically significant relationship between monocyte/HDL-cholesterol and other inflammatory hematological rates (p>0.05). There was a positive, moderate (48.6%), and statistically significant relationship between monocyte/HDL-cholesterol and MLR (p<0.05).
Conclusions: In our study, the NLR, PLR, MLR, and monocyte/HDL-cholesterol values of the obese adolescent group were similar to the control group. There was correlation between monocyte/HDL-cholesterol and monocyte/lymphocyte values. There was no correlation between other rates. Our data do not support the utility of inflammatory hematological rates as a biomarker in adolescent obesity. However, we believe that our study can shed light on other studies to be conducted.


NLR; PLR; MLR; Monocyte/HDL-colesterol; Obesity; Adolescent


Introducción: La obesidad es una enfermedad multifactorial cada vez más importante tanto en niños como en adultos. Los niños y adolescentes obesos tienen un mayor riesgo de volverse obesos en la edad adulta, lo que se asocia con un mayor riesgo de mortalidad y morbilidad. Hay inflamación sistémica subclínica en la obesidad. El estudio tuvo como objetivo evaluar los parámetros hematológicos como indicador de inflamación en adolescentes obesos y mostrar la relación de la relación monocitos/colesterol HDL, que tiene un componente lipídico, con otros parámetros hematológicos inflamatorios.
Materiales y métodos: Se revisaron retrospectivamente los expedientes médicos de 60 pacientes, 30 obesos y 30 controles sanos, con edades comprendidas entre los 11 y los 16 años, que acudieron a la consulta externa de pediatría. Se compararon las pruebas de laboratorio, los parámetros hematológicos, el sexo, la edad y el IMC entre los grupos. Se examinaron las correlaciones entre la proporción de monocitos/colesterol HDL y otros parámetros de laboratorio en el grupo de obesos.
Resultados: Los niveles de IMC, alanina aminotransferasa (ALT), proteína C reactiva (PCR), triglicéridos, insulina y HOMA-IR del grupo de adolescentes obesos fueron estadísticamente significativamente más altos que los del grupo de control (p<0.05). No hubo diferencias estadísticamente significativas entre los grupos de obesidad y de control en términos de proporciones hematológicas inflamatorias (NLR, PLR, MLR y proporción de monocitos/colesterol HDL) (p>0,05). No hubo una relación estadísticamente significativa entre monocitos/colesterol HDL y otras tasas hematológicas inflamatorias (p>0,05). Hubo una relación positiva, moderada (48,6%) y estadísticamente significativa entre monocitos/colesterol HDL y MLR (p <0,05).
Conclusiones: En nuestro estudio, los valores de NLR, PLR, MLR y monocitos/colesterol HDL del grupo de adolescentes obesos fueron similares a los del grupo control. Hubo correlación entre los valores de monocitos/colesterol HDL y monocitos/linfocitos. No hubo correlación entre otras tasas. Nuestros datos no apoyan la utilidad de las tasas hematológicas inflamatorias como biomarcador en la obesidad adolescente. Sin embargo, creemos que nuestro estudio puede arrojar luz sobre otros estudios que se realizarán.

Palabras clave

NLR; PLR; MLR; Monocito/Colesterol HDL; Obesidad; Adolescentes


1. Vos MB, Welsh J. Childhood obesity: update on predisposing factors and prevention strategies. Curr Gastroenterol Rep. 2010;12(4):280-7. doi: 10.1007/s11894-010-0116-1.
2. Martorell R, Kettel Khan L, Hughes ML, Grummer-Strawn LM. Overweight and obesity in preschool children from developing countries. Int J Obes Relat Metab Disord. 2000;24(8):959-67. doi: 10.1038/sj.ijo.0801264.
3. Lifshitz F. Obesity in children. J Clin Res Pediatr Endocrinol. 2008;1(2):53-60. doi: 10.4008/jcrpe.v1i2.35.
4. Llewellyn A, Simmonds M, Owen CG, Woolacott N. Childhood obesity as a predictor of morbidity in adulthood: a systematic review and meta-analysis. Obes Rev. 2016;17(1):56-67. doi: 10.1111/obr.12316.
5. Bahadır A, Baltacı D, Türker Y, Türker Y, Iliev D, Öztürk S, et al. Is the neutrophil-to-lymphocyte ratio indicative of inflammatory state in patients with obesity and metabolic syndrome? Anatol J Cardiol. 2015;15(10):816-22. doi: 10.5152/akd.2014.5787.
6. Inzaugarat ME, Billordo LA, Vodánovich F, Cervini GM, Casavalle PL, Vedire C, et al. Alterations in innate and adaptive immune leukocytes are involved in paediatric obesity. Pediatr Obes. 2014;9(5):381-90. doi: 10.1111/j.2047-6310.2013.00179.x.
7. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006;6(3):173-82. doi: 10.1038/nri1785.
8. Gijsberts CM, Ellenbroek GHJM, Ten Berg MJ, Huisman A, van Solinge WW, Lam CS, et al. Effect of Monocyte-to-Lymphocyte Ratio on Heart Failure Characteristics and Hospitalizations in a Coronary Angiography Cohort. Am J Cardiol. 2017;120(6):911-6. doi: 10.1016/j.amjcard.2017.06.020.
9. Hyun S, Kwon S, Cho S, Park S, Jung W, Moon S, et al. Can the Neutrophil-to-Lymphocyte Ratio Appropriately Predict Carotid Artery Stenosis in Patients with Ischemic Stroke?-A Retrospective Study. J Stroke Cerebrovasc Dis. 2015;24(11):2646-51. doi: 10.1016/j.jstrokecerebrovasdis.2015.07.024.
10. Vakili H, Shirazi M, Charkhkar M, Khaheshi I, Memaryan M, Naderian M. Correlation of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with thrombolysis in myocardial infarction frame count in ST-segment elevation myocardial infarction. Eur J Clin Invest. 2017;47(4):322-7. doi: 10.1111/eci.12736.
11. Mete, B, Değer MS, Zoroğlu G. Relationship between blood lipids, inflammation parameters and body composition. Cukurova Med J. 2020;45(4):1555-61. doi: 10.17826/cumj.740248
12. Aydin M, Yilmaz A, Donma MM, Tulubas F, Demirkol M, Erdogan M, et al. Neutrophil/lymphocyte ratio in obese adolescents. North Clin Istanb. 2015;2(2):87-91. doi: 10.14744/nci.2015.25238.
13. Santos C, Picoito J, Teixeira AL, Rodrigues C, Ferreira S. Platelet to Lymphocyte Ratio and Homeostasis Model Assessment of Insulin Resistance in Pediatric Obesity and Overweight. Rev Port Endocrinol Diabetes Metab. 2017;12(2):177-182. doi: 10.1016/j.rpedm.2016.10.041.
14. Kültürsay H, Yavuzgil O. Obezite ve Kardiyovasküler Risk. Türk Kardiyoloji Seminerleri. 2003;3:129-35.
15. Williams DP, Going SB, Lohman TG, Harsha DW, Srinivasan SR, Webber LS, et al. Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health. 1992;82(3):358-63. doi: 10.2105/ajph.82.3.358.
16. Falk E, Fuster V. Atherogenesis and its determinants. In: Fuster V, Alexander RW, O’Rourke RA, editors. Hurst’s The Heart. 10th ed. New York: McGraw-Hill Medical Publishing Division USA; 2001:1065-93.
17. akubzick CV, Randolph GJ, Henson PM. Monocyte differentiation and antigen-presenting functions. Nat Rev Immunol. 2017;17(6):349-62. doi: 10.1038/nri.2017.28.
18. Ertek S. High-density Lipoprotein (HDL) Dysfunction and the Future of HDL. Curr Vasc Pharmacol. 2018;16(5):490-8. doi: 10.2174/1570161115666171116164612.
19. Ganjali S, Gotto AM Jr, Ruscica M, Atkin SL, Butler AE, Banach M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12):9237-46. doi: 10.1002/jcp.27028.
20. Zhang Y, Li S, Guo YL, Wu NQ, Zhu CG, Gao Y, et al. Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: evidence from a large cohort of Chinese patients undergoing coronary angiography. Ann Med. 2016;48(5):305-12. doi: 10.3109/07853890.2016.1168935.
21. Dincgez Cakmak B, Dundar B, Ketenci Gencer F, Aydin BB, Yildiz DE. TWEAK and monocyte to HDL ratio as a predictor of metabolic syndrome in patients with polycystic ovary syndrome. Gynecol Endocrinol. 2019;35(1):66-71. doi: 10.1080/09513590.2018.1490401.
22. Usta A, Avci E, Bulbul CB, Kadi H, Adali E. The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome. Reprod Biol Endocrinol. 2018;16(1):34. doi: 10.1186/s12958-018-0351-0.
23. Mazıcıoğlu MM, Hatipoğlu N, Oztürk A, Ciçek B, Ustünbaş HB, Kurtoğlu S. Waist circumference and mid-upper arm circumference in evaluation of obesity in children aged between 6 and 17 years. J Clin Res Pediatr Endocrinol. 2010;2(4):144-50. doi: 10.4274/jcrpe.v2i4.144.
24. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415-45. doi: 10.1146/annurev-immunol-031210-101322.
25. Yoshimura A, Ohnishi S, Orito C, Kawahara Y, Takasaki H, Takeda H, et al. Association of peripheral total and differential leukocyte counts with
obesity-related complications in young adults. Obes Facts. 2015;8(1):1-16. doi: 10.1159/000373881.
26. Dilek TD, Gayret ÖB, Kılınç S, Erol M, Yiğit Ö, Mete F. The Assessment of the Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Dyslipidemic Obese Children. Bagcilar Med Bull. 2019;4(3):56-60. doi: 10.4274/BMB.galenos.2019.06.010.
27. Turkmen K, Erdur FM, Ozcicek F, Ozcicek A, Akbas EM, Ozbicer A, et al. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int. 2013;17(3):391-6. doi: 10.1111/hdi.12040.
28. Ji H, Li Y, Fan Z, Zuo B, Jian X, Li L, et al. Monocyte/lymphocyte ratio predicts the severity of coronary artery disease: a syntax score assessment. BMC Cardiovasc Disord. 2017;17(1):90. doi: 10.1186/s12872-017-0507-4.
29. Xiang F, Chen R, Cao X, Shen B, Liu Z, Tan X, et al. Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: A prospective cohort study. Hemodial Int. 2018;22(1):82-92. doi: 10.1111/hdi.12549.
30. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009;27:669-92. doi: 10.1146/annurev.immunol.021908.132557.
31. Linker R, Gold R, Luhder F. Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination. Crit Rev Immunol. 2009;29(1):43-68. doi: 10.1615/critrevimmunol.v29.i1.20.
32. Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1990;1044(2):275-83. doi: 10.1016/0005-2760(90)90314-n.
33. Canpolat U, Çetin EH, Cetin S, Aydin S, Akboga MK, Yayla C, et al. Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation. Clin Appl Thromb Hemost. 2016;22(5):476-82. doi: 10.1177/1076029615594002.
34. Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014;46(8):1619-25. doi: 10.1007/s11255-014-0730-1.
35. Vahit D, Akboga MK, Samet Y, Hüseyin E. Assessment of monocyte to high density lipoprotein cholesterol ratio and lymphocyte-to-monocyte ratio in patients with metabolic syndrome. Biomark Med. 2017;11(7):535-40. doi: 10.2217/bmm-2016-0380.
36. van der Weerd K, Dik WA, Schrijver B, Schweitzer DH, Langerak AW, Drexhage HA, et al. Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg- and Th2-dominated phenotype. Diabetes. 2012;61(2):401-8. doi: 10.2337/db11-1065.

Submitted date:

Reviewed date:

Accepted date:

Publication date:

618ce6b8a953957e2843a154 iberoamericanjm Articles
Links & Downloads

Iberoam J Med

Share this page
Page Sections